echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Harbin Pharmaceutical Group: Simvastatin tablets passed the consistency evaluation of generic drugs

    Harbin Pharmaceutical Group: Simvastatin tablets passed the consistency evaluation of generic drugs

    • Last Update: 2021-06-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On June 7, 2021, Harbin Pharmaceutical Group stated that its subsidiary Harbin Pharmaceutical Group Sanjingmingshui Pharmaceutical Co.
    , Ltd.
    received the "Drug Supplementary Application Approval Document" for Simvastatin tablets issued by the National Medical Products Administration, and the drug passed Consistency evaluation of the quality and efficacy of generic drugs
    .

    Simvastatin tablets are commonly used oral hypolipidemic drugs, the main indications are:

    (1) Hyperlipidemia
    .


    ① For patients with primary hypercholesterolemia, heterozygous familial hypercholesterolemia, or mixed hypercholesterolemia, when diet control and other non-drug treatments are not ideal, simvastatin can be used to reduce elevated total Cholesterol, low-density lipoprotein cholesterol, apolipoprotein B and triglycerides, and simvastatin raises high-density lipoprotein cholesterol, thereby reducing the ratio of low-density lipoprotein/high-density lipoprotein and total cholesterol/high-density lipoprotein


    (2) Coronary heart disease
    .


    ① Reduce the risk of death


    According to relevant national policies, drug varieties that have passed the consistency evaluation of the quality and efficacy of generic drugs will receive greater support in areas such as medical insurance payment and procurement by medical institutions


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.